Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange Detected- Revision: v3.5.4 was added, replacing v3.5.3. This indicates a minor page version update with no changes to study content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s UI version/revision indicator was updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded Naples, Italy, 80131 and updated the revision to v3.5.0. Napoli, Italy, 80131 was changed to Naples and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page layout and navigation were updated, but the core study details and metrics remain unchanged.SummaryDifference0.0%

- Check75 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check96 days agoChange DetectedThis page shows a minor revision update from v3.4.1 to v3.4.2 with no user-visible changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.